Sanofi wins U.S. approval to sell dengue vaccine but with major restrictions

The U.S. Food and Drug Administration on Wednesday gave Sanofi SA's dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine, which took 20 years to develop, can cause severe infections in some people.

from Reuters: Health News https://reut.rs/2IU2Q8Q
via IFTTT